CA2288307A1 - Recepteur activateur nouveau entrant en jeu dans la cytoxicite naturelle induite par les cellules nk humaines et anticorps revelant sa presence - Google Patents

Recepteur activateur nouveau entrant en jeu dans la cytoxicite naturelle induite par les cellules nk humaines et anticorps revelant sa presence Download PDF

Info

Publication number
CA2288307A1
CA2288307A1 CA002288307A CA2288307A CA2288307A1 CA 2288307 A1 CA2288307 A1 CA 2288307A1 CA 002288307 A CA002288307 A CA 002288307A CA 2288307 A CA2288307 A CA 2288307A CA 2288307 A1 CA2288307 A1 CA 2288307A1
Authority
CA
Canada
Prior art keywords
isolated
seq
group
chosen
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002288307A
Other languages
English (en)
Other versions
CA2288307C (fr
Inventor
Alessandro Moretta
Cristina Bottino
Roberto Biassoni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Innate Pharma SA
Universita degli Studi di Genova
Original Assignee
Innate Pharma SA
Universita degli Studi di Genova
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to CA2288307A priority Critical patent/CA2288307C/fr
Application filed by Innate Pharma SA, Universita degli Studi di Genova filed Critical Innate Pharma SA
Priority to DE60041655T priority patent/DE60041655D1/de
Priority to AU26677/01A priority patent/AU783899B2/en
Priority to JP2001538509A priority patent/JP4776845B2/ja
Priority to DK00989877T priority patent/DK1240326T3/da
Priority to AT00989877T priority patent/ATE423848T1/de
Priority to EP00989877A priority patent/EP1240326B1/fr
Priority to PCT/EP2000/011697 priority patent/WO2001036630A2/fr
Priority to ES00989877T priority patent/ES2321687T3/es
Publication of CA2288307A1 publication Critical patent/CA2288307A1/fr
Application granted granted Critical
Publication of CA2288307C publication Critical patent/CA2288307C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA2288307A 1999-11-15 1999-11-15 Recepteur activateur nouveau entrant en jeu dans la cytoxicite naturelle induite par les cellules nk humaines et anticorps revelant sa presence Expired - Fee Related CA2288307C (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
CA2288307A CA2288307C (fr) 1999-11-15 1999-11-15 Recepteur activateur nouveau entrant en jeu dans la cytoxicite naturelle induite par les cellules nk humaines et anticorps revelant sa presence
AU26677/01A AU783899B2 (en) 1999-11-15 2000-11-15 Novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells, and antibodies that identify the same
JP2001538509A JP4776845B2 (ja) 1999-11-15 2000-11-15 ヒトナチュラルキラー細胞によって媒介される天然細胞毒性に関連した新規トリガリングレセプターおよび同一の性質を有する抗体
DK00989877T DK1240326T3 (da) 1999-11-15 2000-11-15 Udlösende receptor der er involveret i naturlig cytotoxicitet medieret af humane naturlige dræberceller og antistoffer som identificerer denne receptor
DE60041655T DE60041655D1 (de) 1999-11-15 2000-11-15 Auslösender rezeptor der an der natürlichen cytotoxizität der menschlichen natürlichen killerzellen (natural killer cells) beteiligt ist und antikörper die diesen rezeptor identifizieren
AT00989877T ATE423848T1 (de) 1999-11-15 2000-11-15 Auslösender rezeptor der an der natürlichen cytotoxizität der menschlichen natürlichen killerzellen (natural killer cells) beteiligt ist und antikörper die diesen rezeptor identifizieren
EP00989877A EP1240326B1 (fr) 1999-11-15 2000-11-15 Recepteur de declenchement implique dans la cytotoxicite naturelle induite par les lymphocytes tueurs naturels (natural killer cells) d'origine humaine et anticorps permettant d'identifier ce recepteur
PCT/EP2000/011697 WO2001036630A2 (fr) 1999-11-15 2000-11-15 Nouveau recepteur de declenchement implique dans la cytotoxicite naturelle induite par les lymphocytes tueurs naturels (nk) et anticorps permettant de l'identifier
ES00989877T ES2321687T3 (es) 1999-11-15 2000-11-15 Receptor activador implicado en la citotoxicidad natural mediada por las celulas destructoras naturales humanas y anticuerpos que identifican dicho receptor.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA2288307A CA2288307C (fr) 1999-11-15 1999-11-15 Recepteur activateur nouveau entrant en jeu dans la cytoxicite naturelle induite par les cellules nk humaines et anticorps revelant sa presence

Publications (2)

Publication Number Publication Date
CA2288307A1 true CA2288307A1 (fr) 2001-05-15
CA2288307C CA2288307C (fr) 2012-05-15

Family

ID=4164540

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2288307A Expired - Fee Related CA2288307C (fr) 1999-11-15 1999-11-15 Recepteur activateur nouveau entrant en jeu dans la cytoxicite naturelle induite par les cellules nk humaines et anticorps revelant sa presence

Country Status (1)

Country Link
CA (1) CA2288307C (fr)

Also Published As

Publication number Publication date
CA2288307C (fr) 2012-05-15

Similar Documents

Publication Publication Date Title
AU784634B2 (en) B7-H1, a novel immunoregulatory molecule
Yokoyama et al. A murine T lymphocyte antigen belongs to a supergene family of type II integral membrane proteins.
JP3542127B2 (ja) ヒトインターフェロン―β２／インターロイキン―６受容体
CA2215394A1 (fr) Recepteur il-17
DE69026627T2 (de) Antikörperantagonisten gegen humanes interleukin-4
US7517966B2 (en) Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells and antibodies that identify the same
EP0433827A2 (fr) Facteur de maturation de lymphocytes cytotoxiques et anticorps monoclonaux dirigés contre celui-ci
HU211627A9 (en) Dna sequences, recombinant dna molecules and methods for obtaining lymphocyte function associated antigen-3
RU99100615A (ru) Новый белок и способ получения этого белка
JP2007530435A5 (fr)
EA003086B1 (ru) ПОЛИПЕПТИДЫ LAG-3V1, LAG-3V2 И LAG-3V3 И КОДИРУЮЩИЕ ИХ кДНК
JPH06505965A (ja) β型トランスフォーミング成長因子
Zwerner et al. Isolation and characterization of murine cell surface components. I. Purification of milligram quantities of Thy-1.1
RU2003121231A (ru) Молчащие анти-cd28-антитела и их применение
JP4776845B2 (ja) ヒトナチュラルキラー細胞によって媒介される天然細胞毒性に関連した新規トリガリングレセプターおよび同一の性質を有する抗体
HU228935B1 (en) Process of purification of hcg and recombinant hcg purified by that method
JP2003523735A5 (fr)
DE69216600T2 (de) Synthetisches CDw52(CAMPATH-1) Peptidantigen
CA2288307A1 (fr) Recepteur activateur nouveau entrant en jeu dans la cytoxicite naturelle induite par les cellules nk humaines et anticorps revelant sa presence
EP0436400B1 (fr) Antigène intracellulaire d'une sous-population de T-lymphocytes CD9-positives et un anticorps monoclonal réagissant avec cela
DE68928902T2 (de) Monoklonaler Antikörper gegen menschliches Lymphotoxin und seine Verwendung
JP3231262B2 (ja) ヒトＴｈ１特異的タンパク質及びこれをコードする遺伝子、並びにこれに関連する形質転換体、組換えベクター及び抗体
CN86108955A (zh) 新的细胞生长调节因子
WO1993016180A3 (fr) Sequences genetiques pour un antigene 90k associe aux tumeurs (ir-95)
JP2575022B2 (ja) ヒトモチリン前駆体、該前駆体含有クローン化ｄｎａ、その調製法並びに該クローン化ｄｎａが組込まれたプラスミド

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20161115